Naveen Pemmaraju, Professor in the Department of Leukemia at UT MD Anderson Cancer Center, shared a post X:
“Delighted to share our brand new paper just out in Blood Journals Portfolio major paper for our BPDCN field TAG/AZA/VEN clinical trial results for patients with BPDCN | led by Andy Lane, Dr Anthony Stein, and Naveen Pemmaraju.
Title: Tagraxofusp, Azacitidine, and Venetoclax in Blastic Plasmacytoid Dendritic Cell Neoplasm
Authors: Andrew A. Lane, Marlise R. Luskin, Julia H. Keating, Nicole R. LeBoeuf, Jacqueline S. Garcia, Shai Shimony, Rebecca Leonard, Adon Goodpaster, Theresa Nguyen, Ilene Galinsky, Ashleigh Eberly Puleo, Naval G. Daver, Nitin Jain, Guillermo Garcia-Manero, Hagop M. Kantarjian, Marina Konopleva, Anthony S. Stein, Naveen Pemmaraju
Read the article here.
Other articles about BPDCN on OncoDaily.